Targeting cellular heterogeneity with CXCR2 blockade for the treatment of therapy-resistant prostate cancer
Authors: Yanjing Li; Yiping Shen; William Butler; Lingfan Xu; Yan Chang; Kefeng Lei; Hong Zhang; Yinglu Zhou; Allen C Gao; Qingfu Zhang; Daniel G Taylor; Donghui Cheng; Suzette Farber-Katz; Rachid Karam; Tyler Landrith; Bing Li; Sitao Wu; Vickie Hsuan; Qing Yang; Hailiang Hu; Xufeng Chen; Melissa Flowers; Shannon J McCall; John K Lee; Bryan A Smith; Jung Wook Park; Andrew S Goldstein; Owen N Witte; Qianben Wang; Matthew B Rettig; Andrew J Armstrong; Qing Cheng; Jiaoti Huang
Collaborators: China Medical University; Duke University School of Medicine; Hangzhou Medical College; The First Affiliated Hospital of Anhui Medical University; University of California Davis School of Medicine; University of California, Los Angeles